Arena Pharmaceuticals Announces Initiation Of Phase 1 Clinical Trial Of APD916 For Narcolepsy And Cataplexy
Links shared publicly online about this topic.
- 1,289total visits
Arena Pharmaceuticals Announces Initiation Of Phase 1 Clinical Trial Of APD916 For Narcolepsy And Cataplexy
View full resource at medicalnewstoday.com
Tags: Neurology, Sleep Disorder, Narcolepsy, Drug, Pharma, Phase 1 Clinical Trial, Clinical Trial
Most Recently Shared on March 25, 2010 at 11:06 pm By:
Arena Pharmaceuticals Announces Initiation Of Phase 1 Clinical Trial Of APD916 For Narcolepsy And Cataplexy http://mnt.to/3zqP
Also Shared By:
Arena reports results of APD916 Phase 1 clinical trial for narcolepsy with cataplexy
news-medical.net — “Arena Pharmaceuticals, Inc. announced today results from a Phase 1 clinical trial of APD916, a novel drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy with cataplexy.” View full resource at news-medical.net
Most Recently Shared on October 20, 2010 at 1:35 pm By:
Arena reports results of APD916 Phase 1 clinical trial for narcolepsy with cataplexy: Arena Pharmaceuticals, Inc. ... http://bit.ly/9PqNAy
Arena Pharmaceuticals initiates patient screening for phase 1 clinical trial of APD916
news-medical.net — “Arena Pharmaceuticals, Inc. announced today the initiation of patient screening in a Phase 1 clinical trial of APD916, a novel oral drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy and cataplexy.” View full resource at news-medical.net
Most Recently Shared on March 25, 2010 at 2:02 pm By:
Arena Pharmaceuticals initiates patient screening for phase 1 clinical trial of APD916: Arena Pharmaceuticals, Inc... http://bit.ly/cIdeCN
Advertisement
MNT Epilepsy News
@mnt_epilepsy
Arena Pharmaceuticals Announces Initiation Of Phase 1 Clinical Trial Of APD916 For Narcolepsy And Cataplexy http://mnt.to/3zqP #epilepsy
1 year ago...